Abstract
Compact counterpulsation (CP) is a novel external counterpulsation system. The preoperative clinical utility of compact CP therapy in patients has not been established. In the present report, we describe a case wherein compact CP therapy was successfully used to treat severe ischemic heart failure. A 70-year-old man was diagnosed with ischemic heart disease and mitral valve regurgitation at 61 years of age. Therefore, he underwent coronary artery bypass and mitral valve plasty. The patient’s condition started to gradually deteriorate at 68 years of age, and he became progressively dependent on catecholamine support. Mitral valve regurgitation recurred, which caused worsening of heart function. Before a mitral valve replacement, the patient had been treated with compact CP therapy to improve heart function and general condition. The patient’s clinical condition improved with compact CP therapy after only ten sessions; in addition, he could be weaned off catecholamine support. No adverse effects were observed, and therefore, he could complete the CP therapy as an outpatient. Mitral valve replacement was performed after a total of 44 sessions. The patient had an uneventful postoperative course and was discharged on the 18th postoperative day. Compact CP therapy was thus performed on our patient without any discomfort and appears to be an effective treatment for patients with severe ischemic heart failure.
Similar content being viewed by others
References
Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, Nesto RW. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999;33:1833–40.
Lawson WE, Hui JC, Cohn PF. Long-term prognosis of patients with angina treated with enhanced external counterpulsation: five-year follow-up study. Clin Cardiol. 2000;23:254–8.
McCullough PA, Silver MA, Kennard ED, Kelsey SF, Michaels AD, IEPR Investigators. Impact of body mass index on outcomes of enhanced external counterpulsation therapy. Am Heart J. 2006;151:139.
Shimizu T, Kyo S, Morizumi S, Ando T, Gon S, Suematsu Y. Effect of external counterpulsation on cardiac work following cardiac surgery: implications of the mechanism responsible for clinical benefits. J Cardiol. 2012;59:84–90.
Shimizu T, Kyo S, Imanaka K, Nakaoka K, Nishimura E, Okumura T, Ishii M, Hisagi M, Nishimura T, Motomura N, Ono M, Takamoto S. A novel external counterpulsation system for coronary artery disease and heart failure: pilot studies and initial clinical experiences. J Artif Organs. 2010;13:161–9.
Taguchi I, Ogawa K, Oida A, Abe S, Kaneko N, Sakio H. Comparison of hemodynamic effects of enhanced external counterpulsation and intra-aortic balloon pumping in patients with acute myocardial infarction. Am J Cardiol. 2000;86:1139–41.
Bonetti PO, Holmes DR Jr, Lerman A, Barsness GW. Enhanced external counterpulsation for ischemic heart disease: what’s behind the curtain? J Am Coll Cardiol. 2003;41:1918–25.
Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol. 2001;37:93–9.
Acknowledgments
The authors are extremely grateful to Ms. Kumiko Kakuya for contributions made during collection and analysis of the study data.
Conflict of interest
The authors declare that they have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kurihara, C., Nishimura, T., Sakano, Y. et al. Novel external counterpulsation system, compact counterpulsation, was effective to treat severe ischemic heart failure: a case report. J Artif Organs 17, 278–280 (2014). https://doi.org/10.1007/s10047-014-0772-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-014-0772-2